Target intelligence / Profile preview

Physical barrier formation on the skin surface

Molecular classification
Other
01

Overview

The **physical barrier formation on the skin surface** is a coordinated multi-step process, primarily achieved by the stratum corneum, the outermost layer of the epidermis[1][2][4][6][9]. This barrier consists of "bricks" (flattened, cornified keratinocytes known as corneocytes) and "mortar" (extracellular lipid matrix, including ceramides, cholesterol, and fatty acids)[1][2]. Key molecular components include filaggrin, involucrin, loricrin, desmosomal proteins, and enzymes responsible for cross-linking proteins and synthesizing lipids[1][7]. The barrier restricts transepidermal water loss, blocks pathogen entry, and minimizes chemical penetration, essential for overall health and prevention of skin disease[1][2][4][6][9]. Barrier dysfunction due to genetic (e.g., filaggrin mutations) or environmental factors leads to dry skin, increased sensitivity, and inflammation,[7] and is a central feature of disorders such as atopic dermatitis and ichthyosis[7]. Therapeutic approaches aim to restore or enhance this barrier, often by supplementing key lipids or proteins, reducing protease activity, or hydrating the stratum corneum[1][4][7].

Other names
Physical skin barrierStratum corneum barrierEpidermal barrierSkin barrier
02

Mechanism of action

Restoration or enhancement of skin barrier integrity (for barrier-improving topical drugs) Modulation of lipid production Promotion of protein cross-linking in the stratum corneum

03

Biological functions

Barrier functionPrevention of transepidermal water lossProtection against pathogens and environmental insultsMaintenance of hydrationImmune sentinel function (involving Langerhans cells, tight junctions)
04

Disease associations

Inflammation (e.g., atopic dermatitis, eczema)Infection (skin susceptible if barrier disrupted)Other (dry skin, ichthyosis, peeling skin diseases)
05

Safety considerations

Barrier-disruptive drugs can increase infection risk and transepidermal water lossOveruse of certain agents may impair barrier repair
06

Biomarkers

Transepidermal water loss (TEWL)Skin hydration/hydration measurementsFilaggrin or ceramide content

Beyond the preview

Go deeper on Physical barrier formation on the skin surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physical barrier formation on the skin surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call